Meeting
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Phenotypic differences in tumor-associated macrophages between metastatic and primary sites of clear cell renal cell carcinoma.
Authors
Yuji Miura
Toranomon Hospital, Tokyo, Japan
Yuji Miura, Takanobu Motoshima, Nanako Wakigami, Natsuki Kusada, Toshikazu Okaneya, Naoko Inoshita, Toshimi Takano, Tomomi Kamba, Yoshihiro Komohara
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Breast and Gynecologic Cancers,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Oncolytic Viruses,Hematologic Malignancies
Sub Track
Biomarkers and Inflammatory Signatures
Citation
J Clin Oncol 36, 2018 (suppl 5S; abstr 105)
DOI
10.1200/JCO.2018.36.5_suppl.105
Abstract #
105
Poster Bd #
G2
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
High expression of sialylated cancer-derived IgG and survival in metastatic clear cell renal cell carcinoma.
First Author: Jie Wu
Poster
2023 ASCO Breakthrough
Effect of low FGFR3 but high CD8 T cell infiltrated immune micro-environment on treatment response with pembrolizumab in upper tract urothelial carcinoma.
First Author: Keisuke Shigeta
Poster
2016 Genitourinary Cancers Symposium
The loss of BAP1 protein expression in the first recurrence site of metastasis to predict prognosis.
First Author: Yuji Miura
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A phase 1 trial of combined MEK, STAT3 and PD-1 inhibition in metastatic pancreatic ductal adenocarcinoma (PDAC).
First Author: Peter Joel Hosein